These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

• J0611

  Injection, calcium gluconate (wg critical care), per 10 ml

• J0612

  Injection, calcium gluconate, not otherwise specified, 10 mg

• J0613

  Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg

• J0614

  Injection, treosulfan, 50 mg

• J0615

  Calcium acetate, oral, 23 mg (for esrd on dialysis)

• J0616

  Injection, metoprolol tartrate, 1 mg

• J0618

  Injection, calcium chloride, 2 mg

• J0620

  Injection, calcium glycerophosphate and calcium lactate, per 10 ml

• J0630

  Injection, calcitonin salmon, up to 400 units

• J0636

  Injection, calcitriol, 0.1 mcg

• J0637

  Injection, caspofungin acetate, 5 mg

• J0638

  Injection, canakinumab, 1 mg

• J0640

  Injection, leucovorin calcium, per 50 mg

• J0641

  Injection, levoleucovorin, not otherwise specified, 0.5 mg

• J0642

  Injection, levoleucovorin (khapzory), 0.5 mg

• J0650

  Injection, levothyroxine sodium, not otherwise specified, 10 mcg

• J0651

  Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg

• J0652

  Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg

• J0654

  Injection, liothyronine, 1 mcg

• J0665

  Injection, bupivicaine, not otherwise specified, 0.5 mg

• J0666

  Injection, bupivacaine liposome, 1 mg

• J0668

  Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg

• J0670

  Injection, mepivacaine hydrochloride, per 10 ml

• J0675

  Injection, carboprost tromethamine, 0.1 mg

• J0681

  Injection, ceftobiprole medocaril sodium, 3 mg

• J0687

  Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg

• J0688

  Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg

• J0689

  Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg

• J0690

  Injection, cefazolin sodium, 500 mg

• J0691

  Injection, lefamulin, 1 mg

• J0692

  Injection, cefepime hydrochloride, 500 mg

• J0693

  Injection, cefiderocol, 5 mg

• J0694

  Injection, cefoxitin sodium, 1 gm

• J0695

  Injection, ceftolozane 50 mg and tazobactam 25 mg

• J0696

  Injection, ceftriaxone sodium, per 250 mg

• J0697

  Injection, sterile cefuroxime sodium, per 750 mg

• J0698

  Injection, cefotaxime sodium, per gm

• J0699

  Injection, cefiderocol, 10 mg

• J0701

  Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg

• J0702

  Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg

• J0703

  Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg

• J0706

  Injection, caffeine citrate, 5 mg

• J0710

  Injection, cephapirin sodium, up to 1 gm

• J0712

  Injection, ceftaroline fosamil, 10 mg

• J0713

  Injection, ceftazidime, per 500 mg

• J0714

  Injection, ceftazidime and avibactam, 0.5 g/0.125 g

• J0715

  Injection, ceftizoxime sodium, per 500 mg

• J0716

  Injection, centruroides immune f(ab)2, up to 120 milligrams

• J0717

  Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

• J0720

  Injection, chloramphenicol sodium succinate, up to 1 gm

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 7/21/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.